Literature DB >> 19353237

Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients.

Korenori Ohtsubo1, Michio Sata2,3,4, Takumi Kawaguchi2,3, Satoshi Morishige5, Yuka Takata5, Eijiro Oku5, Rie Imamura5, Ritsuko Seki5,4, Michitoshi Hashiguchi5, Koichi Osaki5, Kazuaki Yakushiji5, Taisuke Kanaji5, Kohji Yoshimoto5, Takato Ueno4, Takashi Okamura5,4.   

Abstract

To investigate the association between hepatitis C virus (HCV) and B cell proliferation, we searched for the clonal B cells by flow cytometric analysis of the surface immunoglobulin kappa (kappa):lambda (lambda) light chain ratios of the circulating B (CD19+) cells in 240 HCV-positive patients and 150 negative controls with liver diseases. Clonal B cells with light chain restriction (kappa:lambda ratio >3:1 or <1:2) were analyzed for CD5 expression and the presence of monoclonal immunoglobulin heavy-chain (IGH) gene rearrangements and the t(14;18) chromosomal translocation. Clonal B cells were detected in 7 cases with HCV (2.9%), but was never detected in the controls (p < 0.05). Of the 7 cases, all had monoclonal IGH gene rearrangements and one had the t(14;18) chromosomal translocation. These HCV-related clonal B cells are not uniform in the intensity of CD5 expression and showed no increase in the frequencies of CD5+ population compared with non-clonal B cells. No "chronic lymphocytic leukemia-phenotype" cells were found. The loss of clonality was observed in 2 cases treated with interferon and in one case treated with splenectomy. The longitudinal study is required to determine whether these circulating clonal B cells progress to lymphoproliferative disorders in future or not.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19353237     DOI: 10.1007/s12185-009-0301-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  33 in total

1.  Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection.

Authors:  M Ohsawa; N Shingu; H Miwa; H Yoshihara; M Kubo; H Tsukuma; H Teshima; M Hashimoto; K Aozasa
Journal:  Int J Cancer       Date:  1999-01-18       Impact factor: 7.396

2.  Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan.

Authors:  K Tamura; H Sawada; Y Izumi; T Fukuda; A Utsunomiya; S Ikeda; N Uike; J Tsukada; F Kawano; T Shibuya; H Gondo; S Okamura; J Suzumiya
Journal:  Eur J Haematol       Date:  2001-09       Impact factor: 2.997

3.  The majority of peripheral blood monoclonal IgM secreting cells are CD5 negative in three patients with mixed cryoglobulinemia.

Authors:  J L Pasquali; C Waltzinger; J L Kuntz; A M Knapp; H Levallois
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

4.  Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process.

Authors:  V De Re; S De Vita; A Marzotto; A Gloghini; B Pivetta; D Gasparotto; R Cannizzaro; A Carbone; M Boiocchi
Journal:  Int J Cancer       Date:  2000-07-15       Impact factor: 7.396

5.  HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation.

Authors:  Domenico Sansonno; Felicia Anna Tucci; Valli De Re; Gianfranco Lauletta; Michele Montrone; Massimo Libra; Franco Dammacco
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

6.  Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.

Authors:  Eli Zuckerman; Aharon Kessel; Gleb Slobodin; Edmond Sabo; Daniel Yeshurun; Elias Toubi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.

Authors:  Thomas P Giordano; Louise Henderson; Ola Landgren; Elizabeth Y Chiao; Jennifer R Kramer; Hashem El-Serag; Eric A Engels
Journal:  JAMA       Date:  2007-05-09       Impact factor: 56.272

8.  Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms.

Authors:  I Ramasamy; M Brisco; A Morley
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

9.  Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.

Authors:  P Cacoub; M Bourlière; P Hausfater; F Charlotte; H Khiri; S Toci; J C Piette; T Poynard; P Halfon
Journal:  J Viral Hepat       Date:  2003-01       Impact factor: 3.728

10.  Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen.

Authors:  Stephanie Kruetzmann; M Manuela Rosado; Holger Weber; Ulrich Germing; Olivier Tournilhac; Hans-Hartmut Peter; Reinhard Berner; Anke Peters; Thomas Boehm; Alessandro Plebani; Isabella Quinti; Rita Carsetti
Journal:  J Exp Med       Date:  2003-04-07       Impact factor: 14.307

View more
  5 in total

Review 1.  Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization.

Authors:  Takumi Kawaguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

2.  Hepatitis C virus (HCV)-related cryoglobulinemia: cryoglobulin type and anti-HCV profile.

Authors:  Martha Minopetrou; Emilia Hadziyannis; Melanie Deutsch; Maria Tampaki; Asimina Georgiadou; Eleni Dimopoulou; Dimitrios Vassilopoulos; John Koskinas
Journal:  Clin Vaccine Immunol       Date:  2013-03-06

Review 3.  HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role.

Authors:  Giuseppe Sautto; Nicasio Mancini; Laura Solforosi; Roberta A Diotti; Massimo Clementi; Roberto Burioni
Journal:  Clin Dev Immunol       Date:  2012-05-29

Review 4.  Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).

Authors:  Giuseppe Sautto; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-11-08       Impact factor: 5.048

5.  Synchronous ipsilateral carcinoma of the accessory mammary gland and primary lymphoma of the breast with subsequent rectal carcinoma: report of a case.

Authors:  Akihiro Nishikawa; Hide Kasai; Yoshinori Koyama; Naohiko Koide; Akihiro Iijima; Hisashi Shimojo; Shigeyoshi Kumeda
Journal:  World J Surg Oncol       Date:  2014-09-14       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.